Growing Market Presence Tilak Healthcare has successfully introduced OdySight to multiple markets including France, Spain, Belgium, and the US, with a prescription base of 15,000 patients primarily in France. This demonstrates a significant early adoption and market validation, indicating potential for expansion into additional countries and healthcare systems.

Strong Funding Momentum Recent funding rounds totaling over €10 million, led by prominent investors like Elaia and Cap Horn, provide Tilak Healthcare with capital necessary for accelerating product deployment, developing new medical solutions, and capturing larger segments within ophthalmological digital health.

Focus on Chronic Eye Care By targeting chronic ophthalmic conditions with a gamified mobile app supported by healthcare systems, Tilak Healthcare offers a unique value proposition that appeals to healthcare providers seeking innovative, patient engagement-driven monitoring solutions—creating opportunities for partnerships with clinics and health networks.

Innovative Technology Stack Utilizing advanced tech such as cloud services, NoSQL, and analytics platforms, Tilak Healthcare is positioned to develop scalable, data-driven solutions that can be integrated into broader digital health ecosystems, opening avenues for technology partnerships and enterprise sales.

Market Differentiation Potential With a blend of medical expertise and gaming elements, Tilak’s approach offers a compelling differentiation in the digital health space, making it attractive for healthcare organizations looking to improve patient adherence and engagement with innovative, user-friendly tools—driving new sales opportunities in healthcare providers and payers.